ESMO 2024: vídeos e entrevistas
40 vídeos do ESMO 2024 publicados por ESMO, OncLive, Oncology Brothers, ecancer. Atualizado em 20/11/2026.
ESMO W4O Forum 2024 on Empowering women across oncology fieldsESMO · 04/07/2025 · 1:29
ESMO 2024 Lessons in Gynecologic Oncology: Episode 3OncLive · 11/12/2024 · 8:35 · apoio da indústria
ESMO 2024 Lessons in Gynecologic Oncology: Episode 2OncLive · 04/12/2024 · 6:41 · apoio da indústria
ESMO 2024 Lessons in Gynecologic Oncology: Episode 1OncLive · 27/11/2024 · 5:21 · apoio da indústria
Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATICOncology Brothers · 17/10/2024 · 16:10 · apoio da indústria
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2Oncology Brothers · 10/10/2024 · 15:07 · apoio da indústria
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02Oncology Brothers · 03/10/2024 · 20:59 · apoio da indústria
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12Oncology Brothers · 26/09/2024 · 18:38 · apoio da indústria
TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and ...ecancer · 20/09/2024 · 6:35 · apoio da indústria
No benefit for adjuvant durvalumab in completely resected NSCLCecancer · 20/09/2024 · 6:35 · apoio da indústria
PFS increase but no OS increase for niraparib in advanced ovarian cancerecancer · 20/09/2024 · 6:02 · apoio da indústria
Watchful waiting vs intravesical BCG in high grade pT1 bladder cancerecancer · 20/09/2024 · 4:19 · apoio da indústria
Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancerecancer · 20/09/2024 · 4:16 · apoio da indústria
Neoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanomaecancer · 20/09/2024 · 6:14 · apoio da indústria
Faecal microbiota transplantation increases activity of immunotherapy in mRCCecancer · 20/09/2024 · 6:21 · apoio da indústria
Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinomaecancer · 20/09/2024 · 3:11 · apoio da indústria
Total neoadjuvant treatment without surgery for locally advanced rectal cancerecancer · 20/09/2024 · 4:15 · apoio da indústria
Study targets immunotherapy resistance pathways to tailor combination NSCLC therapyecancer · 20/09/2024 · 5:10 · apoio da indústria
Radiation therapy for breast cancer can be safely shortenedecancer · 20/09/2024 · 3:24 · apoio da indústria
Cancer mutation prediction using AIecancer · 20/09/2024 · 4:52 · apoio da indústria
ESMO 2024: Highlights and analysisecancer · 20/09/2024 · 24:35 · apoio da indústria
No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBCecancer · 20/09/2024 · 2:09 · apoio da indústria
Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancerecancer · 20/09/2024 · 4:00 · apoio da indústria
Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectab...ecancer · 20/09/2024 · 8:59 · apoio da indústria
Retifanlimab plus chemo shows PFS benefit in recurrent or metastatic squamous cell carcinoma of ...ecancer · 20/09/2024 · 3:16 · apoio da indústria
Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OSecancer · 20/09/2024 · 3:34 · apoio da indústria
Enzalutamide treatment boosted by Radium-223 in mCRPCecancer · 20/09/2024 · 5:32 · apoio da indústria
TACE combined with Len-Pem shows improved PFS in intermediate stage liver cancerecancer · 20/09/2024 · 4:45 · apoio da indústria
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapiesecancer · 20/09/2024 · 1:31 · apoio da indústria
Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nons...ecancer · 20/09/2024 · 3:04 · apoio da indústria
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancerecancer · 20/09/2024 · 3:06 · apoio da indústria
Addition of relatlimab to nivolumab plus platinum-doublet chemotherapy demonstrates improved cli...ecancer · 20/09/2024 · 4:21 · apoio da indústria
Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE...ecancer · 20/09/2024 · 5:58 · apoio da indústria
NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCCecancer · 20/09/2024 · 1:40 · apoio da indústria
Nivolumab plus ipilimumab improves efficacy versus standard of care in non-clear-cell renal cell...ecancer · 20/09/2024 · 4:08 · apoio da indústria
Repeat immune checkpoint inhibitor therapy not recommended for aRCCecancer · 20/09/2024 · 2:19 · apoio da indústria
ESMO 2024: Join your international community in Barcelona, or OnlineESMO · 22/07/2024 · 1:57
ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equityESMO · 20/06/2024 · 1:01
#ESMO24: F. André, R. Dent, M. Garassino, M. Van der Heijden & M. Lambertini invite you to attendESMO · 07/06/2024 · 1:09
ESMO 2024: A. Cervantes, R. Dent, K. Jordan & others give powerful reasons to submit your workESMO · 27/02/2024 · 2:14